Back

Association between white blood cell-based inflammatory markers and the severity of rheumatic mitral stenosis in a tertiary referral hospital in Indonesia

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Mitral stenosis and rheumatic heart disease Rheumatic Heart Disease ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Abida Hasna Laila

Hasna Medika Bandung Heart Clinic, Bandung (Indonesia)

5 More presentations in this session

Presentation thumbnail
Feasibility and midterm outcomes of mitral valve repair in rheumatic heart disease: a multicenter study with multimodal imaging insights
Doctor S. Jia (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Rheumatic heart disease prevalence in migrant populations in germany, a pilot study
Doctor M. Steinmaurer (Munich, DE)
Abstract Slides Video
Presentation thumbnail
Percutaneous transvenous mitral commissurotomy: In hospital and intermediate term follow up outcome from a prosepctive registry
Doctor R. Partheeban (Chennai, IN)
Abstract Slides Video
Presentation thumbnail
Quality of surgical care for rheumatic heart disease patients: insights from the Netherlands Heart Registration
Miss L. De Wilde (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Hyperhomocysteinemia and mitral valve calcification in rheumatic heart disease: insights from a novel multi-modality imaging approach
Doctor S. Jia (Beijing, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Mitral stenosis and rheumatic heart disease

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Differentiation of severe from non-severe mitral stenosis with dimensionless index and its prognostic implications in patients with rheumatic mitral stenosis
thumbnail
Congress Presentation
The role of novel biomarkers of systemic inflammation in the hospitalisation of patients with aortic stenosis
thumbnail
Congress Presentation
Natural progression of rheumatic aortic valve disease following rheumatic mitral valve intervention: 16-year single center experience

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources